LEIGH SYNDROME DRUG DISCOVERY WITH INDUCED NEURONS AND MIDBRAIN ORGANOIDS UNVEILS A REPOSITIONABLE COMPOUND
Main Authors: | Carmen Menacho, Satoshi Okawa, Laura Petersilie, Annette Seibt, Markus Schülke, Felix Distelmaier, Christine R. Rose, Antonio Del Sol, Alessandro Prigione |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | IBRO Neuroscience Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667242123003470 |
Similar Items
-
HIGH-THROUGHPUT KNOCKDOWN SCREENING FOR MODIFIERS OF NEURONAL MORPHOLOGY IN LEIGH SYNDROME PATIENT-DERIVED NEURONS
by: Selene Lickfett, et al.
Published: (2023-10-01) -
Rammeskift og repositionering
by: Anne Mette Brøgger Breining, et al.
Published: (2022-06-01) -
Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality
by: Sabate-Soler, S, et al.
Published: (2022) -
The design and fabrication of a passive and continuously repositionable joint
by: Daniel, Phillip Howard
Published: (2014) -
Protocol for generating reproducible miniaturized controlled midbrain organoids
by: Muwan Chen, et al.
Published: (2023-09-01)